EuroAPI

15 rue Traversière
75012 Paris
France

Contact WebSite

At EUROAPI, we’re reinventing active ingredient solutions to meet customers’ and patients’ needs around the world in a sustainable way.

Article

23.05.2024 • News

EuroAPI Secures €130-150 Million Animal Health Contract

EuroAPI has entered into a Contract Manufacturing Organization (CMO) agreement with a global animal health company.

19.03.2024 • News

2024 Guidance Suspended: API Production Paused in Brindisi, Italy

EuroAPI today announces that its Italian subsidiary, EuroAPI Italy S.R.L., is suspending the production of all APIs (active pharmaceutical ingredients) in Brindisi.

26.01.2024 • News

EuroAPI Collaborates with Contract Research Organization SpiroChem

Active pharmaceutical ingredients manufacturer EuroAPI has started a collaboration with Basel, Switzerland-headquartered SpiroChem, a contract research organization (CRO) which specializes in early chemical process R&D (route scouting).

22.11.2023 • News

EuroAPI Completes Acquisition of BianoGMP

EuroAPI has completed the acquisition of BianoGMP, a contract development and manufacturing organization (CDMO) specializing in oligonucleotides.

26.10.2023 • News

EuroAPI Announces New Governance

EuroAPI's Board of Directors decided that Karl Rotthier would step down as CEO, effective October 30, 2023. They initiated the search for a new CEO and appointed Viviane Monges, the current Board Chair, as interim CEO until a permanent successor is found, while she continues her role as Board Chair.

13.10.2022 • Topics • Chemistry

Ensuring API Supply Capacities for Europe and Beyond

Interview with Karl Rotthier, CEO of the Sanofi spin-off EuroAPI.